JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1700433

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalinowski, L
Right arrow Articles by Malinski, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalinowski, L
Right arrow Articles by Malinski, T
Journal of Endocrinology, Vol 170, Issue 2, 433-440
Copyright © 2001 by Society for Endocrinology


Articles

Nitric oxide as a second messenger in parathyroid hormone-related protein signaling

L Kalinowski, LW Dobrucki, and T Malinski


Parathyroid hormone (PTH)-related protein (PTHrP) is produced in smooth muscles and endothelial cells and is believed to participate in the local regulation of vascular tone. No direct evidence for the activation of endothelium-derived nitric oxide (NO) signaling pathway by PTHrP has been found despite attempts to identify it. Based on direct in situ measurements, it is reported here for the first time that the human PTH/PTHrP receptor analogs, hPTH(1--34) and hPTHrP(1--34), stimulate NO release from a single endothelial cell. A highly sensitive porphyrinic microsensor with a response time of 0.1 ms and a detection limit of 1 nmol/l was used for the measurement of NO. Both hPTH(1--34) and hPTHrP(1--34) stimulated NO release at nanomolar concentrations. The peak concentration of 0.1 micromol/l hPTH(1--34)- and 0.1 micromol/l hPTHrP(1--34)-stimulated NO release was 175+/-9 and 248+/-13 nmol/l respectively. This represents about 30%--40% of maximum NO concentration recorded in the presence of (0.1 micromol/l) calcium ionophore. Two competitive PTH/PTHrP receptor antagonists, 10 micromol/l [Leu(11),d -Trp(12)]-hPTHrP(7--34)amide and 10 micromol/l [Nle(8,18),Tyr(34)]-bPTH(3--34)amide, were equipotent in antagonizing hPTH(1--34)-stimulated NO release; [Leu(11),d -Trp(12)]-hPTHrP(7--34)amide was more potent than [Nle(8,18),Tyr(34)]-bPTH(3--34)amide in inhibiting hPTHrP(1--34)-stimulated NO release. The PKC inhibitor, H-7 (50 micromol/l), did not change hPTH(1--34)- and hPTHrP(1--34)-stimulated NO release, whereas the combined effect of 10 micromol/l of the cAMP antagonist, Rp-cAMPS, and 50 micromol/l of the calmodulin inhibitor, W-7, was additive. The present studies show that both hPTH(1--34) and hPTHrP(1--34) activate NO production in endothelial cells. The activation of NO release is through PTH/PTHrP receptors and is mediated via the calcium/calmodulin pathway.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Rashid, J. Bernheim, J. Green, and S. Benchetrit
Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2831 - 2837.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Mahon, T. M. Bonacci, P. Divieti, and A. V. Smrcka
A Docking Site for G Protein {beta}{gamma} Subunits on the Parathyroid Hormone 1 Receptor Supports Signaling through Multiple Pathways
Mol. Endocrinol., January 1, 2006; 20(1): 136 - 146.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. E. Godler, A. N. Stein, O. Bakharevski, M. M. L. Lindsay, and P. F. J. Ryan
Parathyroid hormone-related peptide expression in rat collagen-induced arthritis
Rheumatology, September 1, 2005; 44(9): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao and J. U. Raj
Parathyroid hormone-related protein-mediated responses in pulmonary arteries and veins of newborn lambs
Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L60 - L66.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Meziani, B. Van Overloop, F. Schneider, and A. Gairard
Parathyroid Hormone-Related Protein-induced Relaxation of Rat Uterine Arteries: Influence of the Endothelium During Gestation
Reproductive Sciences, January 1, 2005; 12(1): 14 - 19.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. H. Hastings, F. Araiza, D. W. Burton, M. Bedley, and L. J. Deftos
Parathyroid hormone-related protein regulates apoptosis in lung cancer cells through protein kinase A
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1616 - C1622.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig
Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Olearczyk, M. L. Ellsworth, A. H. Stephenson, A. J. Lonigro, and R. S. Sprague
Nitric Oxide Inhibits ATP Release from Erythrocytes
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1079 - 1084.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Mahon, J. A. Cole, E. D. Lederer, and G. V. Segre
Na+/H+ Exchanger-Regulatory Factor 1 Mediates Inhibition of Phosphate Transport by Parathyroid Hormone and Second Messengers by Acting at Multiple Sites in Opossum Kidney Cells
Mol. Endocrinol., November 1, 2003; 17(11): 2355 - 2364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. D. Bakker, M. Joldersma, J. Klein-Nulend, and E. H. Burger
Interactive effects of PTH and mechanical stress on nitric oxide and PGE2 production by primary mouse osteoblastic cells
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E608 - E613.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Ogata, E. Ritz, G. Odoni, K. Amann, and S. R. Orth
Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 959 - 967.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.